Iht Wealth Management, LLC Novavax Inc Transaction History

Iht Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $177,266 - $269,768	-997 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $31,460 - $66,994	-260 Reduced 20.68%	997 $212,000
Q1 2021 May 18, 2021	BUY	$112.98 - $319.93 $134,672 - $381,356	1,192 Added 1833.85%	1,257 $228,000
Q4 2020 Feb 17, 2021	SELL	$78.74 - $139.5 $242,361 - $429,381	-3,078 Reduced 97.93%	65 $265,000
Q3 2020 Nov 19, 2020	SELL	$79.44 - $178.51 $377,737 - $848,815	-4,755 Reduced 60.21%	3,143 $595,000
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $109,466 - $660,351	7,898 New	7,898 $658,000

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.